Clinical Trials List
2017-09-01 - 2023-04-20
Phase III
Terminated4
ICD-10C53.0
Malignant neoplasm of endocervix
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9180.0
Malignant neoplasm of endocervix
-
Trial Applicant
Syneos Health
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yi-Jen Chen Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳鵬宇 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
34 participants
-
Global
608 participants
